跳至主要内容
临床试验/NCT05230784
NCT05230784招募中不适用

Effectiveness of Indoor Air Purifiers on Heart Failure Outcomes

NYU Langone Health3 个研究点 分布在 1 个国家目标入组 255 人开始时间: 2024年3月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
255
试验地点
3
主要终点
Change in Distance Walked

研究概览

简要总结

Indoor air pollution and fine mode particulate matter with an aerodynamic diameter smaller than 2.5 micrometers (PM2.5) is a major contributor to global morbidity and mortality, particularly due to cardiovascular disease. This project aims to demonstrate the efficacy, feasibility and effectiveness of portable air filters in improving indoor PM2.5 levels and improving functional capacity of heart failure patients with reduced ejection fraction in India. The findings from the project will add to existing knowledge of innovative and scalable strategies to improve environmental and cardiovascular health worldwide.

The overall objective of this study is to demonstrate the efficacy, feasibility, and effectiveness of portable air filters in improving indoor PM2.5 levels and improving functional capacity of heart failure patients with reduced ejection fraction in India.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥ 18 years of age diagnosed with HF with a reduced ejection fraction of ≤ 40% within the last six months in NYHA class II-IV.

排除标准

  • listed for a cardiac transplant
  • history of CRT device implantation in last 3 months
  • on oxygen therapy
  • with severe pulmonary disease
  • participants unable to ambulate

研究组 & 干预措施

HEPA Air Purifier

Experimental

Air purifier is installed in participants' households by the research team. Twice per year, participants will wear a GPS as well as a backpack containing a particulate matter 2.5 (PM2.5) personal exposure monitor for a 24-hour monitoring period.

干预措施: AirOk Air Purifier (Other)

EGAPA Air Purifier

Placebo Comparator

Air purifier is installed in participants' households by the research team. Twice per year, participants will wear a GPS as well as a backpack containing a particulate matter 2.5 (PM2.5) personal exposure monitor for a 24-hour monitoring period.

干预措施: Placebo Air Filter (Other)

结局指标

主要结局

Change in Distance Walked

时间窗: Baseline, 12 months

The distance in meters will be recorded during a 6-minute walk test (MWT)

次要结局

  • Change in pro B-type natriuretic peptide (Pro-BNP) Levels(Baseline, 12 months)
  • Change in Systolic Blood Pressure (SBP)(Baseline, 12 months)
  • Change in Diastolic Blood Pressure (DBP)(Baseline, 12 months)
  • Change in Number of Hospitalizations(Baseline, 12 months)
  • Change in Heart Rate(Baseline, 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验